nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—ABCB1—peripheral nervous system neoplasm	0.286	1	CbGaD
Nisoldipine—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0532	0.114	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0532	0.114	CbGbCtD
Nisoldipine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0399	0.0854	CbGbCtD
Nisoldipine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.032	0.0684	CbGbCtD
Nisoldipine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.028	0.0598	CbGbCtD
Nisoldipine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.028	0.0598	CbGbCtD
Nisoldipine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0256	0.0546	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0244	0.0523	CbGbCtD
Nisoldipine—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0244	0.0523	CbGbCtD
Nisoldipine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0194	0.0414	CbGbCtD
Nisoldipine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0183	0.0392	CbGbCtD
Nisoldipine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0168	0.0359	CbGbCtD
Nisoldipine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0168	0.0358	CbGbCtD
Nisoldipine—CACNA1S—pes—peripheral nervous system neoplasm	0.0167	0.379	CbGeAlD
Nisoldipine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0156	0.0333	CbGbCtD
Nisoldipine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0125	0.0267	CbGbCtD
Nisoldipine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0119	0.0255	CbGbCtD
Nisoldipine—CACNA1D—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0119	0.271	CbGeAlD
Nisoldipine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0111	0.0238	CbGbCtD
Nisoldipine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0109	0.0234	CbGbCtD
Nisoldipine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00746	0.0159	CbGbCtD
Nisoldipine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00715	0.0153	CbGbCtD
Nisoldipine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00655	0.014	CbGbCtD
Nisoldipine—CACNA1D—cochlea—peripheral nervous system neoplasm	0.00604	0.137	CbGeAlD
Nisoldipine—CACNA1D—internal ear—peripheral nervous system neoplasm	0.00573	0.13	CbGeAlD
Nisoldipine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00447	0.00955	CbGbCtD
Nisoldipine—CACNA2D1—brainstem—peripheral nervous system neoplasm	0.00112	0.0254	CbGeAlD
Nisoldipine—Clevidipine—BCHE—peripheral nervous system neoplasm	0.000906	0.405	CrCbGaD
Nisoldipine—CACNA1S—NCAM1 interactions—NCAM1—peripheral nervous system neoplasm	0.000617	0.0424	CbGpPWpGaD
Nisoldipine—CACNB2—cerebellum—peripheral nervous system neoplasm	0.000588	0.0133	CbGeAlD
Nisoldipine—CACNA2D1—cerebellum—peripheral nervous system neoplasm	0.000553	0.0125	CbGeAlD
Nisoldipine—CACNB2—NCAM1 interactions—NCAM1—peripheral nervous system neoplasm	0.000529	0.0363	CbGpPWpGaD
Nisoldipine—CACNA1D—cerebellum—peripheral nervous system neoplasm	0.000514	0.0117	CbGeAlD
Nisoldipine—CACNA1D—NCAM1 interactions—NCAM1—peripheral nervous system neoplasm	0.000501	0.0344	CbGpPWpGaD
Nisoldipine—CACNA1C—cerebellum—peripheral nervous system neoplasm	0.000475	0.0108	CbGeAlD
Nisoldipine—CACNA1C—NCAM1 interactions—NCAM1—peripheral nervous system neoplasm	0.00044	0.0302	CbGpPWpGaD
Nisoldipine—CACNA1S—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.000364	0.025	CbGpPWpGaD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—NCAM1—peripheral nervous system neoplasm	0.000363	0.0249	CbGpPWpGaD
Nisoldipine—CYP3A5—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000336	0.0231	CbGpPWpGaD
Nisoldipine—Nitrendipine—ABCB1—peripheral nervous system neoplasm	0.000318	0.142	CrCbGaD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—NCAM1—peripheral nervous system neoplasm	0.000311	0.0214	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.000296	0.0203	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—NCAM1—peripheral nervous system neoplasm	0.000295	0.0202	CbGpPWpGaD
Nisoldipine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000284	0.00645	CbGeAlD
Nisoldipine—Amlodipine—ABCB1—peripheral nervous system neoplasm	0.000274	0.122	CrCbGaD
Nisoldipine—CACNA1C—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.00026	0.0179	CbGpPWpGaD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—NCAM1—peripheral nervous system neoplasm	0.000259	0.0178	CbGpPWpGaD
Nisoldipine—Felodipine—ABCB1—peripheral nervous system neoplasm	0.000253	0.113	CrCbGaD
Nisoldipine—Nifedipine—ABCB1—peripheral nervous system neoplasm	0.000245	0.109	CrCbGaD
Nisoldipine—Nicardipine—ABCB1—peripheral nervous system neoplasm	0.000241	0.108	CrCbGaD
Nisoldipine—CACNB2—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.000223	0.0153	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000213	0.0146	CbGpPWpGaD
Nisoldipine—CACNA1D—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.000211	0.0145	CbGpPWpGaD
Nisoldipine—CACNA1C—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.000185	0.0127	CbGpPWpGaD
Nisoldipine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000184	0.0126	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000183	0.0125	CbGpPWpGaD
Nisoldipine—CACNB2—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.000179	0.0123	CbGpPWpGaD
Nisoldipine—CACNB2—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.000175	0.012	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000173	0.0119	CbGpPWpGaD
Nisoldipine—CACNA1D—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00017	0.0116	CbGpPWpGaD
Nisoldipine—CACNA1D—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.000166	0.0114	CbGpPWpGaD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.00016	0.011	CbGpPWpGaD
Nisoldipine—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000156	0.0107	CbGpPWpGaD
Nisoldipine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000156	0.000841	CcSEcCtD
Nisoldipine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000156	0.000839	CcSEcCtD
Nisoldipine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000838	CcSEcCtD
Nisoldipine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000155	0.000836	CcSEcCtD
Nisoldipine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.000833	CcSEcCtD
Nisoldipine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000154	0.000832	CcSEcCtD
Nisoldipine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000154	0.000831	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000154	0.00083	CcSEcCtD
Nisoldipine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000829	CcSEcCtD
Nisoldipine—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000829	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000826	CcSEcCtD
Nisoldipine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000153	0.000825	CcSEcCtD
Nisoldipine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000153	0.000825	CcSEcCtD
Nisoldipine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000153	0.000824	CcSEcCtD
Nisoldipine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000822	CcSEcCtD
Nisoldipine—CACNA1S—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000152	0.0104	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000152	0.0104	CbGpPWpGaD
Nisoldipine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000152	0.000818	CcSEcCtD
Nisoldipine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000151	0.000816	CcSEcCtD
Nisoldipine—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000813	CcSEcCtD
Nisoldipine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000151	0.000813	CcSEcCtD
Nisoldipine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00015	0.00081	CcSEcCtD
Nisoldipine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00015	0.000806	CcSEcCtD
Nisoldipine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00015	0.000806	CcSEcCtD
Nisoldipine—CACNA1C—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.000149	0.0102	CbGpPWpGaD
Nisoldipine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000148	0.000795	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000795	CcSEcCtD
Nisoldipine—Rash—Topotecan—peripheral nervous system neoplasm	0.000147	0.000793	CcSEcCtD
Nisoldipine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000147	0.000793	CcSEcCtD
Nisoldipine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000147	0.000792	CcSEcCtD
Nisoldipine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000792	CcSEcCtD
Nisoldipine—Cough—Etoposide—peripheral nervous system neoplasm	0.000146	0.000789	CcSEcCtD
Nisoldipine—Headache—Topotecan—peripheral nervous system neoplasm	0.000146	0.000788	CcSEcCtD
Nisoldipine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000146	0.000787	CcSEcCtD
Nisoldipine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000146	0.000787	CcSEcCtD
Nisoldipine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000787	CcSEcCtD
Nisoldipine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000146	0.000786	CcSEcCtD
Nisoldipine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000146	0.000786	CcSEcCtD
Nisoldipine—CACNA1C—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.000146	0.01	CbGpPWpGaD
Nisoldipine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000145	0.000782	CcSEcCtD
Nisoldipine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000145	0.000782	CcSEcCtD
Nisoldipine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.00078	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000779	CcSEcCtD
Nisoldipine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000145	0.000779	CcSEcCtD
Nisoldipine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000777	CcSEcCtD
Nisoldipine—Rash—Melphalan—peripheral nervous system neoplasm	0.000144	0.000777	CcSEcCtD
Nisoldipine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000144	0.000776	CcSEcCtD
Nisoldipine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000772	CcSEcCtD
Nisoldipine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000143	0.00077	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000769	CcSEcCtD
Nisoldipine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000143	0.000768	CcSEcCtD
Nisoldipine—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000767	CcSEcCtD
Nisoldipine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000766	CcSEcCtD
Nisoldipine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000141	0.000761	CcSEcCtD
Nisoldipine—CACNB2—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.000141	0.00967	CbGpPWpGaD
Nisoldipine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00014	0.000753	CcSEcCtD
Nisoldipine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000752	CcSEcCtD
Nisoldipine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000139	0.000752	CcSEcCtD
Nisoldipine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.000751	CcSEcCtD
Nisoldipine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.000748	CcSEcCtD
Nisoldipine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000139	0.000747	CcSEcCtD
Nisoldipine—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000745	CcSEcCtD
Nisoldipine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000138	0.000745	CcSEcCtD
Nisoldipine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000743	CcSEcCtD
Nisoldipine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000138	0.000741	CcSEcCtD
Nisoldipine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000138	0.000741	CcSEcCtD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.000137	0.00944	CbGpPWpGaD
Nisoldipine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000136	0.000734	CcSEcCtD
Nisoldipine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000733	CcSEcCtD
Nisoldipine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000136	0.000732	CcSEcCtD
Nisoldipine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000728	CcSEcCtD
Nisoldipine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000728	CcSEcCtD
Nisoldipine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000728	CcSEcCtD
Nisoldipine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000134	0.000724	CcSEcCtD
Nisoldipine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000134	0.000721	CcSEcCtD
Nisoldipine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000134	0.000721	CcSEcCtD
Nisoldipine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000719	CcSEcCtD
Nisoldipine—CACNA1D—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.000133	0.00916	CbGpPWpGaD
Nisoldipine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000133	0.000719	CcSEcCtD
Nisoldipine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000714	CcSEcCtD
Nisoldipine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000132	0.000714	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000712	CcSEcCtD
Nisoldipine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000709	CcSEcCtD
Nisoldipine—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000131	0.00898	CbGpPWpGaD
Nisoldipine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000131	0.000704	CcSEcCtD
Nisoldipine—CACNB2—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00013	0.00895	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.00013	0.00894	CbGpPWpGaD
Nisoldipine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000701	CcSEcCtD
Nisoldipine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00013	0.000698	CcSEcCtD
Nisoldipine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.000697	CcSEcCtD
Nisoldipine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000128	0.00069	CcSEcCtD
Nisoldipine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00069	CcSEcCtD
Nisoldipine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000687	CcSEcCtD
Nisoldipine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000681	CcSEcCtD
Nisoldipine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000673	CcSEcCtD
Nisoldipine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000673	CcSEcCtD
Nisoldipine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000673	CcSEcCtD
Nisoldipine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000672	CcSEcCtD
Nisoldipine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000125	0.000672	CcSEcCtD
Nisoldipine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.000669	CcSEcCtD
Nisoldipine—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000124	0.00282	CbGeAlD
Nisoldipine—CACNA1D—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000123	0.00848	CbGpPWpGaD
Nisoldipine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000123	0.000664	CcSEcCtD
Nisoldipine—CACNA1S—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000123	0.00846	CbGpPWpGaD
Nisoldipine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000123	0.000663	CcSEcCtD
Nisoldipine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000662	CcSEcCtD
Nisoldipine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000658	CcSEcCtD
Nisoldipine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000122	0.000658	CcSEcCtD
Nisoldipine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000122	0.000656	CcSEcCtD
Nisoldipine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.000647	CcSEcCtD
Nisoldipine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000119	0.000643	CcSEcCtD
Nisoldipine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000119	0.000642	CcSEcCtD
Nisoldipine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000637	CcSEcCtD
Nisoldipine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000633	CcSEcCtD
Nisoldipine—CACNA1C—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.000117	0.00805	CbGpPWpGaD
Nisoldipine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000631	CcSEcCtD
Nisoldipine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00063	CcSEcCtD
Nisoldipine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000626	CcSEcCtD
Nisoldipine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000116	0.000624	CcSEcCtD
Nisoldipine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000622	CcSEcCtD
Nisoldipine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000622	CcSEcCtD
Nisoldipine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000619	CcSEcCtD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—PTPN11—peripheral nervous system neoplasm	0.000114	0.00786	CbGpPWpGaD
Nisoldipine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000613	CcSEcCtD
Nisoldipine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000612	CcSEcCtD
Nisoldipine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000609	CcSEcCtD
Nisoldipine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000609	CcSEcCtD
Nisoldipine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000113	0.000608	CcSEcCtD
Nisoldipine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000112	0.000606	CcSEcCtD
Nisoldipine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000112	0.000603	CcSEcCtD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000111	0.00762	CbGpPWpGaD
Nisoldipine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.000596	CcSEcCtD
Nisoldipine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.000596	CcSEcCtD
Nisoldipine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000594	CcSEcCtD
Nisoldipine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000593	CcSEcCtD
Nisoldipine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000109	0.000587	CcSEcCtD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000109	0.00747	CbGpPWpGaD
Nisoldipine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000585	CcSEcCtD
Nisoldipine—CACNA1C—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000108	0.00745	CbGpPWpGaD
Nisoldipine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000584	CcSEcCtD
Nisoldipine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000108	0.000584	CcSEcCtD
Nisoldipine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000584	CcSEcCtD
Nisoldipine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.00058	CcSEcCtD
Nisoldipine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000578	CcSEcCtD
Nisoldipine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000576	CcSEcCtD
Nisoldipine—Rash—Vincristine—peripheral nervous system neoplasm	0.000107	0.000575	CcSEcCtD
Nisoldipine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000107	0.000574	CcSEcCtD
Nisoldipine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000574	CcSEcCtD
Nisoldipine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000573	CcSEcCtD
Nisoldipine—Headache—Vincristine—peripheral nervous system neoplasm	0.000106	0.000571	CcSEcCtD
Nisoldipine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000566	CcSEcCtD
Nisoldipine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000563	CcSEcCtD
Nisoldipine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.000562	CcSEcCtD
Nisoldipine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000561	CcSEcCtD
Nisoldipine—CACNA1S—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000104	0.00715	CbGpPWpGaD
Nisoldipine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000551	CcSEcCtD
Nisoldipine—CACNA1S—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000102	0.00701	CbGpPWpGaD
Nisoldipine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000101	0.000544	CcSEcCtD
Nisoldipine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000543	CcSEcCtD
Nisoldipine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000101	0.00692	CbGpPWpGaD
Nisoldipine—Nausea—Vincristine—peripheral nervous system neoplasm	0.0001	0.000541	CcSEcCtD
Nisoldipine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00054	CcSEcCtD
Nisoldipine—CACNA1D—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.0001	0.00687	CbGpPWpGaD
Nisoldipine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.000536	CcSEcCtD
Nisoldipine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000535	CcSEcCtD
Nisoldipine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.000531	CcSEcCtD
Nisoldipine—Chills—Epirubicin—peripheral nervous system neoplasm	9.7e-05	0.000523	CcSEcCtD
Nisoldipine—Pruritus—Etoposide—peripheral nervous system neoplasm	9.69e-05	0.000522	CcSEcCtD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	9.64e-05	0.00662	CbGpPWpGaD
Nisoldipine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000519	CcSEcCtD
Nisoldipine—Alopecia—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.000515	CcSEcCtD
Nisoldipine—Rash—Cisplatin—peripheral nervous system neoplasm	9.43e-05	0.000508	CcSEcCtD
Nisoldipine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.42e-05	0.000508	CcSEcCtD
Nisoldipine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.37e-05	0.000505	CcSEcCtD
Nisoldipine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	9.33e-05	0.000503	CcSEcCtD
Nisoldipine—Flatulence—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.0005	CcSEcCtD
Nisoldipine—Tension—Epirubicin—peripheral nervous system neoplasm	9.23e-05	0.000498	CcSEcCtD
Nisoldipine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000497	CcSEcCtD
Nisoldipine—Nervousness—Epirubicin—peripheral nervous system neoplasm	9.14e-05	0.000493	CcSEcCtD
Nisoldipine—Dizziness—Etoposide—peripheral nervous system neoplasm	9.06e-05	0.000488	CcSEcCtD
Nisoldipine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000488	CcSEcCtD
Nisoldipine—Chills—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.000484	CcSEcCtD
Nisoldipine—CACNB2—Axon guidance—NCAM1—peripheral nervous system neoplasm	8.92e-05	0.00613	CbGpPWpGaD
Nisoldipine—Nausea—Cisplatin—peripheral nervous system neoplasm	8.88e-05	0.000479	CcSEcCtD
Nisoldipine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000476	CcSEcCtD
Nisoldipine—CACNA1C—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	8.79e-05	0.00604	CbGpPWpGaD
Nisoldipine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.000471	CcSEcCtD
Nisoldipine—Anaemia—Epirubicin—peripheral nervous system neoplasm	8.7e-05	0.000469	CcSEcCtD
Nisoldipine—Rash—Etoposide—peripheral nervous system neoplasm	8.64e-05	0.000466	CcSEcCtD
Nisoldipine—Dermatitis—Etoposide—peripheral nervous system neoplasm	8.63e-05	0.000465	CcSEcCtD
Nisoldipine—Headache—Etoposide—peripheral nervous system neoplasm	8.58e-05	0.000463	CcSEcCtD
Nisoldipine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000462	CcSEcCtD
Nisoldipine—Tension—Doxorubicin—peripheral nervous system neoplasm	8.54e-05	0.00046	CcSEcCtD
Nisoldipine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.00046	CcSEcCtD
Nisoldipine—Malaise—Epirubicin—peripheral nervous system neoplasm	8.49e-05	0.000457	CcSEcCtD
Nisoldipine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	8.46e-05	0.000456	CcSEcCtD
Nisoldipine—Vertigo—Epirubicin—peripheral nervous system neoplasm	8.45e-05	0.000456	CcSEcCtD
Nisoldipine—CACNA1D—Axon guidance—NCAM1—peripheral nervous system neoplasm	8.45e-05	0.0058	CbGpPWpGaD
Nisoldipine—Syncope—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000455	CcSEcCtD
Nisoldipine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.42e-05	0.000454	CcSEcCtD
Nisoldipine—CACNB2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.39e-05	0.00576	CbGpPWpGaD
Nisoldipine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000451	CcSEcCtD
Nisoldipine—CACNB2—Neuronal System—BCHE—peripheral nervous system neoplasm	8.33e-05	0.00572	CbGpPWpGaD
Nisoldipine—Palpitations—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000448	CcSEcCtD
Nisoldipine—CACNA1D—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	8.28e-05	0.00569	CbGpPWpGaD
Nisoldipine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000446	CcSEcCtD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	8.27e-05	0.00568	CbGpPWpGaD
Nisoldipine—Cough—Epirubicin—peripheral nervous system neoplasm	8.21e-05	0.000443	CcSEcCtD
Nisoldipine—Nausea—Etoposide—peripheral nervous system neoplasm	8.14e-05	0.000439	CcSEcCtD
Nisoldipine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000435	CcSEcCtD
Nisoldipine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	8.05e-05	0.000434	CcSEcCtD
Nisoldipine—Myalgia—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000432	CcSEcCtD
Nisoldipine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000432	CcSEcCtD
Nisoldipine—Chest pain—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000432	CcSEcCtD
Nisoldipine—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.00043	CcSEcCtD
Nisoldipine—CACNA1D—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.95e-05	0.00546	CbGpPWpGaD
Nisoldipine—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.000427	CcSEcCtD
Nisoldipine—Malaise—Doxorubicin—peripheral nervous system neoplasm	7.85e-05	0.000423	CcSEcCtD
Nisoldipine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.83e-05	0.000422	CcSEcCtD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	7.83e-05	0.00538	CbGpPWpGaD
Nisoldipine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	0.000422	CcSEcCtD
Nisoldipine—Syncope—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000421	CcSEcCtD
Nisoldipine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	7.79e-05	0.00042	CcSEcCtD
Nisoldipine—Confusional state—Epirubicin—peripheral nervous system neoplasm	7.74e-05	0.000417	CcSEcCtD
Nisoldipine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.000415	CcSEcCtD
Nisoldipine—Oedema—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000414	CcSEcCtD
Nisoldipine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000412	CcSEcCtD
Nisoldipine—Cough—Doxorubicin—peripheral nervous system neoplasm	7.6e-05	0.000409	CcSEcCtD
Nisoldipine—Shock—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.000407	CcSEcCtD
Nisoldipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	7.5e-05	0.00515	CbGpPWpGaD
Nisoldipine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000404	CcSEcCtD
Nisoldipine—CACNA1S—Developmental Biology—NCAM1—peripheral nervous system neoplasm	7.43e-05	0.0051	CbGpPWpGaD
Nisoldipine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.0004	CcSEcCtD
Nisoldipine—CACNA1C—Axon guidance—NCAM1—peripheral nervous system neoplasm	7.42e-05	0.0051	CbGpPWpGaD
Nisoldipine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.000399	CcSEcCtD
Nisoldipine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.000399	CcSEcCtD
Nisoldipine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.000399	CcSEcCtD
Nisoldipine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000398	CcSEcCtD
Nisoldipine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000395	CcSEcCtD
Nisoldipine—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.32e-05	0.000395	CcSEcCtD
Nisoldipine—CACNA1C—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	7.28e-05	0.005	CbGpPWpGaD
Nisoldipine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.000391	CcSEcCtD
Nisoldipine—Hypotension—Epirubicin—peripheral nervous system neoplasm	7.18e-05	0.000387	CcSEcCtD
Nisoldipine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	7.16e-05	0.000386	CcSEcCtD
Nisoldipine—Oedema—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000383	CcSEcCtD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	7.05e-05	0.00485	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	7e-05	0.00481	CbGpPWpGaD
Nisoldipine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000377	CcSEcCtD
Nisoldipine—Shock—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000377	CcSEcCtD
Nisoldipine—CACNA1C—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.98e-05	0.0048	CbGpPWpGaD
Nisoldipine—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000374	CcSEcCtD
Nisoldipine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000374	CcSEcCtD
Nisoldipine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.000372	CcSEcCtD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—NRAS—peripheral nervous system neoplasm	6.88e-05	0.00472	CbGpPWpGaD
Nisoldipine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.00037	CcSEcCtD
Nisoldipine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.000369	CcSEcCtD
Nisoldipine—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000368	CcSEcCtD
Nisoldipine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000365	CcSEcCtD
Nisoldipine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.76e-05	0.000364	CcSEcCtD
Nisoldipine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.00036	CcSEcCtD
Nisoldipine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000358	CcSEcCtD
Nisoldipine—CACNA1S—Alzheimers Disease—TP53—peripheral nervous system neoplasm	6.54e-05	0.00449	CbGpPWpGaD
Nisoldipine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	6.47e-05	0.000349	CcSEcCtD
Nisoldipine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000346	CcSEcCtD
Nisoldipine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000344	CcSEcCtD
Nisoldipine—CACNB2—Developmental Biology—NCAM1—peripheral nervous system neoplasm	6.37e-05	0.00437	CbGpPWpGaD
Nisoldipine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000341	CcSEcCtD
Nisoldipine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000341	CcSEcCtD
Nisoldipine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.00034	CcSEcCtD
Nisoldipine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000337	CcSEcCtD
Nisoldipine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.000333	CcSEcCtD
Nisoldipine—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.1e-05	0.000329	CcSEcCtD
Nisoldipine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	6.08e-05	0.00417	CbGpPWpGaD
Nisoldipine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.07e-05	0.000327	CcSEcCtD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	6.05e-05	0.00415	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—NCAM1—peripheral nervous system neoplasm	6.03e-05	0.00414	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	5.87e-05	0.00403	CbGpPWpGaD
Nisoldipine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000316	CcSEcCtD
Nisoldipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	5.79e-05	0.00398	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	5.73e-05	0.00393	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.67e-05	0.00389	CbGpPWpGaD
Nisoldipine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000305	CcSEcCtD
Nisoldipine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000304	CcSEcCtD
Nisoldipine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000303	CcSEcCtD
Nisoldipine—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.000293	CcSEcCtD
Nisoldipine—CACNA1D—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.37e-05	0.00369	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—TP53—peripheral nervous system neoplasm	5.31e-05	0.00365	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—NCAM1—peripheral nervous system neoplasm	5.3e-05	0.00364	CbGpPWpGaD
Nisoldipine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000283	CcSEcCtD
Nisoldipine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000282	CcSEcCtD
Nisoldipine—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000274	CcSEcCtD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—peripheral nervous system neoplasm	5.03e-05	0.00346	CbGpPWpGaD
Nisoldipine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000271	CcSEcCtD
Nisoldipine—CACNA1S—Axon guidance—MET—peripheral nervous system neoplasm	4.97e-05	0.00342	CbGpPWpGaD
Nisoldipine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000262	CcSEcCtD
Nisoldipine—Rash—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000261	CcSEcCtD
Nisoldipine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000261	CcSEcCtD
Nisoldipine—Headache—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000259	CcSEcCtD
Nisoldipine—CACNA1C—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.72e-05	0.00324	CbGpPWpGaD
Nisoldipine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000253	CcSEcCtD
Nisoldipine—CACNA1C—Alzheimers Disease—TP53—peripheral nervous system neoplasm	4.67e-05	0.00321	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—PTPN11—peripheral nervous system neoplasm	4.6e-05	0.00316	CbGpPWpGaD
Nisoldipine—Nausea—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000246	CcSEcCtD
Nisoldipine—Rash—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000241	CcSEcCtD
Nisoldipine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000241	CcSEcCtD
Nisoldipine—Headache—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.00024	CcSEcCtD
Nisoldipine—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.28e-05	0.00294	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—MET—peripheral nervous system neoplasm	4.26e-05	0.00293	CbGpPWpGaD
Nisoldipine—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000227	CcSEcCtD
Nisoldipine—CACNB2—Metabolism—GNS—peripheral nervous system neoplasm	4.1e-05	0.00281	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—MET—peripheral nervous system neoplasm	4.04e-05	0.00277	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—PTPN11—peripheral nervous system neoplasm	3.94e-05	0.00271	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—NME1—peripheral nervous system neoplasm	3.93e-05	0.0027	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GNS—peripheral nervous system neoplasm	3.88e-05	0.00267	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—COX2—peripheral nervous system neoplasm	3.78e-05	0.0026	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—PTPN11—peripheral nervous system neoplasm	3.73e-05	0.00256	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—NME1—peripheral nervous system neoplasm	3.72e-05	0.00256	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—ERBB2—peripheral nervous system neoplasm	3.63e-05	0.0025	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—COX2—peripheral nervous system neoplasm	3.58e-05	0.00246	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—MET—peripheral nervous system neoplasm	3.55e-05	0.00244	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—MET—peripheral nervous system neoplasm	3.55e-05	0.00244	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GNS—peripheral nervous system neoplasm	3.41e-05	0.00234	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—PTPN11—peripheral nervous system neoplasm	3.28e-05	0.00225	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—PTPN11—peripheral nervous system neoplasm	3.28e-05	0.00225	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—NME1—peripheral nervous system neoplasm	3.27e-05	0.00225	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—COX2—peripheral nervous system neoplasm	3.15e-05	0.00216	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—ERBB2—peripheral nervous system neoplasm	3.12e-05	0.00214	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.09e-05	0.00212	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—MET—peripheral nervous system neoplasm	3.04e-05	0.00209	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—ERBB2—peripheral nervous system neoplasm	2.95e-05	0.00203	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.89e-05	0.00198	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—MET—peripheral nervous system neoplasm	2.88e-05	0.00198	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.88e-05	0.00198	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.82e-05	0.00194	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—PTPN11—peripheral nervous system neoplasm	2.81e-05	0.00193	CbGpPWpGaD
Nisoldipine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.78e-05	0.00191	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—NRAS—peripheral nervous system neoplasm	2.77e-05	0.0019	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—PTPN11—peripheral nervous system neoplasm	2.66e-05	0.00183	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.62e-05	0.0018	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.59e-05	0.00178	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—ERBB2—peripheral nervous system neoplasm	2.59e-05	0.00178	CbGpPWpGaD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.55e-05	0.00175	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—MET—peripheral nervous system neoplasm	2.53e-05	0.00174	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	2.51e-05	0.00172	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—ENO2—peripheral nervous system neoplasm	2.48e-05	0.00171	CbGpPWpGaD
Nisoldipine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.43e-05	0.00167	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.4e-05	0.00165	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—NRAS—peripheral nervous system neoplasm	2.37e-05	0.00163	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—ENO2—peripheral nervous system neoplasm	2.35e-05	0.00162	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—PTPN11—peripheral nervous system neoplasm	2.34e-05	0.00161	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	2.34e-05	0.0016	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.33e-05	0.0016	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—NRAS—peripheral nervous system neoplasm	2.25e-05	0.00154	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.24e-05	0.00154	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.22e-05	0.00153	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.11e-05	0.00145	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—BCHE—peripheral nervous system neoplasm	2.1e-05	0.00144	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	2.09e-05	0.00143	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.09e-05	0.00143	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—ENO2—peripheral nervous system neoplasm	2.07e-05	0.00142	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—HRAS—peripheral nervous system neoplasm	2.02e-05	0.00139	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	2e-05	0.00138	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2e-05	0.00137	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—BCHE—peripheral nervous system neoplasm	1.99e-05	0.00136	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.97e-05	0.00136	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—NRAS—peripheral nervous system neoplasm	1.97e-05	0.00135	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—TH—peripheral nervous system neoplasm	1.97e-05	0.00135	CbGpPWpGaD
Nisoldipine—CACNB2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.95e-05	0.00134	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.93e-05	0.00132	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.9e-05	0.0013	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—TH—peripheral nervous system neoplasm	1.87e-05	0.00128	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.86e-05	0.00128	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.85e-05	0.00127	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.83e-05	0.00126	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—BCHE—peripheral nervous system neoplasm	1.75e-05	0.0012	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—HRAS—peripheral nervous system neoplasm	1.73e-05	0.00119	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.69e-05	0.00116	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.67e-05	0.00114	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—HRAS—peripheral nervous system neoplasm	1.64e-05	0.00113	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—TH—peripheral nervous system neoplasm	1.64e-05	0.00113	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—GNAS—peripheral nervous system neoplasm	1.61e-05	0.00111	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.6e-05	0.0011	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.58e-05	0.00109	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.58e-05	0.00108	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—GNAS—peripheral nervous system neoplasm	1.53e-05	0.00105	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.52e-05	0.00104	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.51e-05	0.00104	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—ABCB1—peripheral nervous system neoplasm	1.5e-05	0.00103	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.45e-05	0.000994	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.44e-05	0.000992	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—HRAS—peripheral nervous system neoplasm	1.44e-05	0.000991	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.44e-05	0.000987	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.41e-05	0.000967	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.39e-05	0.000957	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—GNAS—peripheral nervous system neoplasm	1.34e-05	0.00092	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.32e-05	0.000908	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—ABCB1—peripheral nervous system neoplasm	1.31e-05	0.000903	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.27e-05	0.000876	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.27e-05	0.000869	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.26e-05	0.000864	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.24e-05	0.00085	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.2e-05	0.000824	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.19e-05	0.000816	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.17e-05	0.000805	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.14e-05	0.000782	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000751	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.09e-05	0.00075	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.07e-05	0.000734	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.05e-05	0.000722	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.05e-05	0.000718	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.03e-05	0.000711	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.03e-05	0.000707	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.02e-05	0.0007	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.01e-05	0.00069	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.71e-06	0.000667	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.56e-06	0.000656	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.37e-06	0.000643	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	9.15e-06	0.000628	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—AKT1—peripheral nervous system neoplasm	9.09e-06	0.000625	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	9.09e-06	0.000625	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	8.72e-06	0.000599	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	8.39e-06	0.000576	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	8.21e-06	0.000564	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	8.05e-06	0.000553	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	7.73e-06	0.000531	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.69e-06	0.000528	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.37e-06	0.000506	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	7.27e-06	0.000499	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.02e-06	0.000482	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	6.9e-06	0.000474	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.73e-06	0.000462	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.5e-06	0.000446	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.48e-06	0.000445	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	5.93e-06	0.000407	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.83e-06	0.000401	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	5.82e-06	0.0004	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.56e-06	0.000382	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	5.51e-06	0.000378	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.48e-06	0.000377	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	4.66e-06	0.00032	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.48e-06	0.000307	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.44e-06	0.000305	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	4.38e-06	0.000301	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—AKT1—peripheral nervous system neoplasm	4.35e-06	0.000299	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.25e-06	0.000292	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—AKT1—peripheral nervous system neoplasm	4.12e-06	0.000283	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—AKT1—peripheral nervous system neoplasm	3.62e-06	0.000248	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.59e-06	0.000247	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.57e-06	0.000245	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.51e-06	0.000241	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.43e-06	0.000235	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.38e-06	0.000232	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.76e-06	0.000189	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.71e-06	0.000186	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.21e-06	0.000152	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.6e-06	0.00011	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.21e-06	8.3e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	9.64e-07	6.62e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.44e-07	5.11e-05	CbGpPWpGaD
